Page last updated: 2024-10-29

imipramine and Neural Tube Defects

imipramine has been researched along with Neural Tube Defects in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Neural Tube Defects: Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy generally occurring between days 18-29 of gestation. Ectodermal and mesodermal malformations (mainly involving the skull and vertebrae) may occur as a result of defects of neural tube closure. (From Joynt, Clinical Neurology, 1992, Ch55, pp31-41)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hurley, RM1
Harris, D1
Shepherd, RR1

Trials

1 trial available for imipramine and Neural Tube Defects

ArticleYear
Incontinence in myelodysplasia: imipramine hydrochloride revisited.
    Clinical pediatrics, 2000, Volume: 39, Issue:8

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Child; Child, Preschool; Dose-Respon

2000